Details for New Drug Application (NDA): 050823
✉ Email this page to a colleague
NDA 050823 describes CEFTAZIDIME IN DEXTROSE CONTAINER, which is a drug marketed by B Braun and is included in one NDA. Additional details are available on the CEFTAZIDIME IN DEXTROSE CONTAINER profile page.
The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 050823
| Tradename: | CEFTAZIDIME IN DEXTROSE CONTAINER |
| Applicant: | B Braun |
| Ingredient: | ceftazidime |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050823
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE | ||||
| Approval Date: | Jun 13, 2011 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE | ||||
| Approval Date: | Jun 13, 2011 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
